{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:46:37Z","timestamp":1791492397525,"version":"4.3.4"},"reference-count":181,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"ostgraduate Scientific Research and Innovation Project of Chongqing Municipal Education Commission, China","award":["No. CYB240233"],"award-info":[{"award-number":["No. CYB240233"]}]},{"name":"Science and Technology Research Program of Chongqing Municipal Education Commission, China","award":["No. KJQN202400552"],"award-info":[{"award-number":["No. KJQN202400552"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12602-025-10853-3","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:37:01Z","timestamp":1767857821000},"page":"6329-6364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Designing the Next Generation of Endolysins: A Triple Strategy Integrating Bioinformatics Mining, Engineering Modification and Encapsulation Formulation"],"prefix":"10.1007","volume":"18","author":[{"given":"Yongkang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinge","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luwei","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangwei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingying","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"10853_CR1","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/s0140-6736(24)01885-3","volume":"404","author":"S Kariuki","year":"2024","unstructured":"Kariuki S (2024) Global burden of antimicrobial resistance and forecasts to 2050. Lancet 404:1172\u20131173. https:\/\/doi.org\/10.1016\/s0140-6736(24)01885-3","journal-title":"Lancet"},{"key":"10853_CR2","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/nature.2014.15135","volume":"244","author":"S Reardon","year":"2014","unstructured":"Reardon S (2014) WHO warns against \u2018post-antibiotic\u2019 era. Nature 244:1356\u20131357. https:\/\/doi.org\/10.1038\/nature.2014.15135","journal-title":"Nature"},{"key":"10853_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","volume":"186","author":"SA Strathdee","year":"2023","unstructured":"Strathdee SA, Hatfull GF, Mutalik VK, Schooley RT (2023) Phage therapy: from biological mechanisms to future directions. Cell 186:17\u201331. https:\/\/doi.org\/10.1016\/j.cell.2022.11.017","journal-title":"Cell"},{"key":"10853_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02629-16","volume":"61","author":"SY Jun","year":"2017","unstructured":"Jun SY, Jang IJ, Yoon S, Jang K, Yu KS, Cho JY, Seong MW, Jung GM, Yoon SJ, Kang SH (2017) Pharmacokinetics and tolerance of the phage endolysin-based candidate drug SAL200 after a single intravenous administration among healthy volunteers. Antimicrob Agents Chemother 61:10.1128\/aac.02629\u2009\u2212\u200902616. https:\/\/doi.org\/10.1128\/aac.02629-16","journal-title":"Antimicrob Agents Chemother"},{"key":"10853_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/s1473-3099(15)00466-1","volume":"16","author":"L Czaplewski","year":"2016","unstructured":"Czaplewski L, Bax R, Clokie M, Dawson M, Fairhead H, Fischetti VA, Foster S, Gilmore BF, Hancock RE, Harper D, Henderson IR, Hilpert K, Jones BV, Kadioglu A, Knowles D, \u00d3lafsd\u00f3ttir S, Payne D, Projan S, Shaunak S, Silverman J, Thomas CM, Trust TJ, Warn P, Rex JH (2016) Alternatives to antibiotics-a pipeline portfolio review. Lancet Infect Dis 16:239\u2013251. https:\/\/doi.org\/10.1016\/s1473-3099(15)00466-1","journal-title":"Lancet Infect Dis"},{"key":"10853_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/621316","volume":"2014","author":"G Verbeken","year":"2014","unstructured":"Verbeken G, Huys I, Pirnay JP, Jennes S, Chanishvili N, Scheres J, G\u00f3rski A, De Vos D, Ceulemans C (2014) Taking bacteriophage therapy seriously: a moral argument. BioMed Res Int 2014:621316. https:\/\/doi.org\/10.1155\/2014\/621316","journal-title":"BioMed Res Int"},{"key":"10853_CR7","unstructured":"FDA (2018) Expanded Access Program Report_May_2018. https:\/\/www.fda.gov\/media\/119971. Accessed 9 Jun 2025"},{"key":"10853_CR8","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1128\/jvi.03277-12","volume":"87","author":"H Oliveira","year":"2013","unstructured":"Oliveira H, Melo LD, Santos SB, N\u00f3brega FL, Ferreira EC, Cerca N, Azeredo J, Kluskens LD (2013) Molecular aspects and comparative genomics of bacteriophage endolysins. J Virol 87:4558\u20134570. https:\/\/doi.org\/10.1128\/jvi.03277-12","journal-title":"J Virol"},{"key":"10853_CR9","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.biotechadv.2017.12.009","volume":"36","author":"H Gerstmans","year":"2018","unstructured":"Gerstmans H, Criel B, Briers Y (2018) Synthetic biology of modular endolysins. Biotechnol Adv 36:624\u2013640. https:\/\/doi.org\/10.1016\/j.biotechadv.2017.12.009","journal-title":"Biotechnol Adv"},{"key":"10853_CR10","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1146\/annurev.micro.54.1.799","volume":"54","author":"IN Wang","year":"2000","unstructured":"Wang IN, Smith DL, Young R (2000) Holins: the protein clocks of bacteriophage infections. Annu Rev Microbiol 54:799\u2013825. https:\/\/doi.org\/10.1146\/annurev.micro.54.1.799","journal-title":"Annu Rev Microbiol"},{"key":"10853_CR11","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.mib.2013.08.008","volume":"16","author":"R Young","year":"2013","unstructured":"Young R (2013) Phage lysis: do we have the hole story yet? Curr Opin Microbiol 16:790\u2013797. https:\/\/doi.org\/10.1016\/j.mib.2013.08.008","journal-title":"Curr Opin Microbiol"},{"key":"10853_CR12","doi-asserted-by":"publisher","first-page":"E2054","DOI":"10.1073\/pnas.1222283110","volume":"110","author":"T Pang","year":"2013","unstructured":"Pang T, Fleming TC, Pogliano K, Young R (2013) Visualization of pinholin lesions in vivo. Proc Natl Acad Sci U S A 110:E2054-2063. https:\/\/doi.org\/10.1073\/pnas.1222283110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10853_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1126\/science.1105143","volume":"307","author":"M Xu","year":"2005","unstructured":"Xu M, Arulandu A, Struck DK, Swanson S, Sacchettini JC, Young R (2005) Disulfide isomerization after membrane release of its SAR domain activates P1 lysozyme. Science 307:113\u2013117. https:\/\/doi.org\/10.1126\/science.1105143","journal-title":"Science"},{"key":"10853_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7030084","volume":"7","author":"N Matamp","year":"2019","unstructured":"Matamp N, Bhat SG (2019) Phage endolysins as potential antimicrobials against multidrug resistant Vibrio alginolyticusand Vibrio parahaemolyticus: current status of research and challenges ahead. Microorganisms 7:84. https:\/\/doi.org\/10.3390\/microorganisms7030084","journal-title":"Microorganisms"},{"key":"10853_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4161\/bact.1.1.13980","volume":"1","author":"ST Abedon","year":"2011","unstructured":"Abedon ST (2011) Lysis from without. Bacteriophage 1:46\u201349. https:\/\/doi.org\/10.4161\/bact.1.1.13980","journal-title":"Bacteriophage"},{"key":"10853_CR16","doi-asserted-by":"publisher","first-page":"6276","DOI":"10.1128\/aac.01701-13","volume":"57","author":"F Oechslin","year":"2013","unstructured":"Oechslin F, Daraspe J, Giddey M, Moreillon P, Resch G (2013) In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae bacteremia. Antimicrob Agents Chemother 57:6276\u20136283. https:\/\/doi.org\/10.1128\/aac.01701-13","journal-title":"Antimicrob Agents Chemother"},{"key":"10853_CR17","doi-asserted-by":"publisher","first-page":"e02462","DOI":"10.1128\/aem.02462-18","volume":"85","author":"M Kong","year":"2019","unstructured":"Kong M, Na H, Ha NC, Ryu S (2019) LysPBC2, a novel endolysin harboring a Bacillus cereus spore binding domain. Appl Environ Microbiol 85:e02462\u2013e02418. https:\/\/doi.org\/10.1128\/aem.02462-18","journal-title":"Appl Environ Microbiol"},{"key":"10853_CR18","doi-asserted-by":"publisher","first-page":"24990","DOI":"10.1074\/jbc.M704317200","volume":"282","author":"I P\u00e9rez-Dorado","year":"2007","unstructured":"P\u00e9rez-Dorado I, Campillo NE, Monterroso B, Hesek D, Lee M, P\u00e1ez JA, Garc\u00eda P, Mart\u00ednez-Ripoll M, Garc\u00eda JL, Mobashery S, Men\u00e9ndez M, Hermoso JA (2007) Elucidation of the molecular recognition of bacterial cell wall by modular pneumococcal phage endolysin CPL-1. J Biol Chem 282:24990\u201324999. https:\/\/doi.org\/10.1074\/jbc.M704317200","journal-title":"J Biol Chem"},{"key":"10853_CR19","doi-asserted-by":"publisher","first-page":"10765","DOI":"10.1073\/pnas.0604521103","volume":"103","author":"D Nelson","year":"2006","unstructured":"Nelson D, Schuch R, Chahales P, Zhu S, Fischetti VA (2006) PlyC: a multimeric bacteriophage lysin. Proc Natl Acad Sci U S A 103:10765\u201310770. https:\/\/doi.org\/10.1073\/pnas.0604521103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10853_CR20","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1128\/jb.124.3.1067-1076.1975","volume":"124","author":"JV H\u00f6ltje","year":"1975","unstructured":"H\u00f6ltje JV, Mirelman D, Sharon N, Schwarz U (1975) Novel type of murein transglycosylase in Escherichia coli. J Bacteriol 124:1067\u20131076. https:\/\/doi.org\/10.1128\/jb.124.3.1067-1076.1975","journal-title":"J Bacteriol"},{"key":"10853_CR21","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/367750a0","volume":"367","author":"AM Thunnissen","year":"1994","unstructured":"Thunnissen AM, Dijkstra AJ, Kalk KH, Rozeboom HJ, Engel H, Keck W, Dijkstra BW (1994) Doughnut-shaped structure of a bacterial muramidase revealed by X-ray crystallography. Nature 367:750\u2013753. https:\/\/doi.org\/10.1038\/367750a0","journal-title":"Nature"},{"key":"10853_CR22","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.bbamem.2007.06.007","volume":"1778","author":"W Vollmer","year":"2008","unstructured":"Vollmer W, Bertsche U (2008) Murein (peptidoglycan) structure, architecture and biosynthesis in Escherichia coli. Biochim Biophys Acta 1778:1714\u20131734. https:\/\/doi.org\/10.1016\/j.bbamem.2007.06.007","journal-title":"Biochim Biophys Acta"},{"key":"10853_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1128\/br.36.4.407-477.1972","volume":"36","author":"KH Schleifer","year":"1972","unstructured":"Schleifer KH, Kandler O (1972) Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 36:407\u2013477. https:\/\/doi.org\/10.1128\/br.36.4.407-477.1972","journal-title":"Bacteriol Rev"},{"key":"10853_CR24","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.mib.2005.06.002","volume":"8","author":"MJ Loessner","year":"2005","unstructured":"Loessner MJ (2005) Bacteriophage endolysins\u2013current state of research and applications. Curr Opin Microbiol 8:480\u2013487. https:\/\/doi.org\/10.1016\/j.mib.2005.06.002","journal-title":"Curr Opin Microbiol"},{"key":"10853_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1574-6976.2007.00088.x","volume":"32","author":"W Vollmer","year":"2008","unstructured":"Vollmer W (2008) Structural variation in the glycan strands of bacterial peptidoglycan. FEMS Microbiol Rev 32:287\u2013306. https:\/\/doi.org\/10.1111\/j.1574-6976.2007.00088.x","journal-title":"FEMS Microbiol Rev"},{"key":"10853_CR26","doi-asserted-by":"publisher","first-page":"34391","DOI":"10.1074\/jbc.M111.244160","volume":"286","author":"LY Low","year":"2011","unstructured":"Low LY, Yang C, Perego M, Osterman A, Liddington R (2011) Role of net charge on catalytic domain and influence of cell wall binding domain on bactericidal activity, specificity, and host range of phage lysins. J Biol Chem 286:34391\u201334403. https:\/\/doi.org\/10.1074\/jbc.M111.244160","journal-title":"J Biol Chem"},{"key":"10853_CR27","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.1038\/s41598-019-42435-z","volume":"9","author":"P Mitkowski","year":"2019","unstructured":"Mitkowski P, Jagielska E, Nowak E, Bujnicki JM, Stefaniak F, Niedzia\u0142ek D, Bochtler M, Saba\u0142a I (2019) Structural bases of peptidoglycan recognition by lysostaphin SH3b domain. Sci Rep 9:5965. https:\/\/doi.org\/10.1038\/s41598-019-42435-z","journal-title":"Sci Rep"},{"key":"10853_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41589-019-0393-4","volume":"16","author":"LS Gonzalez-Delgado","year":"2020","unstructured":"Gonzalez-Delgado LS, Walters-Morgan H, Salamaga B, Robertson AJ, Hounslow AM, Jagielska E, Saba\u0142a I, Williamson MP, Lovering AL, Mesnage S (2020) Two-site recognition of Staphylococcus aureus peptidoglycan by lysostaphin SH3b. Nat Chem Biol 16:24\u201330. https:\/\/doi.org\/10.1038\/s41589-019-0393-4","journal-title":"Nat Chem Biol"},{"key":"10853_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422x-11-133","volume":"11","author":"M Sanz-Gaitero","year":"2014","unstructured":"Sanz-Gaitero M, Keary R, Garcia-Doval C, Coffey A, van Raaij MJ (2014) Crystal structure of the lytic CHAP(K) domain of the endolysin LysK from Staphylococcus aureus bacteriophage K. Virol J 11:133. https:\/\/doi.org\/10.1186\/1743-422x-11-133","journal-title":"Virol J"},{"key":"10853_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1046\/j.1365-2958.2002.02889.x","volume":"44","author":"MJ Loessner","year":"2002","unstructured":"Loessner MJ, Kramer K, Ebel F, Scherer S (2002) C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates. Mol Microbiol 44:335\u2013349. https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02889.x","journal-title":"Mol Microbiol"},{"key":"10853_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2672.2007.03498.x","volume":"104","author":"A Parisien","year":"2008","unstructured":"Parisien A, Allain B, Zhang J, Mandeville R, Lan CQ (2008) Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. J Appl Microbiol 104:1\u201313. https:\/\/doi.org\/10.1111\/j.1365-2672.2007.03498.x","journal-title":"J Appl Microbiol"},{"key":"10853_CR32","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1099\/mic.0.000190","volume":"161","author":"AA Pohane","year":"2015","unstructured":"Pohane AA, Jain V (2015) Insights into the regulation of bacteriophage endolysin: multiple means to the same end. Microbiology (Reading, Engl.) 161:2269\u20132276. https:\/\/doi.org\/10.1099\/mic.0.000190","journal-title":"Microbiology (Reading, Engl.)"},{"key":"10853_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/1751-7915.14465","volume":"17","author":"T Zheng","year":"2024","unstructured":"Zheng T, Zhang C (2024) Engineering strategies and challenges of endolysin as an antibacterial agent against Gram-negative bacteria. Microb Biotechnol 17:e14465. https:\/\/doi.org\/10.1111\/1751-7915.14465","journal-title":"Microb Biotechnol"},{"key":"10853_CR34","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/j.1365-2958.2007.05870.x","volume":"65","author":"Y Briers","year":"2007","unstructured":"Briers Y, Volckaert G, Cornelissen A, Lagaert S, Michiels CW, Hertveldt K, Lavigne R (2007) Muralytic activity and modular structure of the endolysins of Pseudomonas aeruginosa bacteriophages PhiKZ and EL. Mol Microbiol 65:1334\u20131344. https:\/\/doi.org\/10.1111\/j.1365-2958.2007.05870.x","journal-title":"Mol Microbiol"},{"key":"10853_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bbrc.2009.03.161","volume":"383","author":"Y Briers","year":"2009","unstructured":"Briers Y, Schmelcher M, Loessner MJ, Hendrix J, Engelborghs Y, Volckaert G, Lavigne R (2009) The high-affinity peptidoglycan binding domain of Pseudomonas phage endolysin KZ144. Biochem Biophys Res Commun 383:187\u2013191. https:\/\/doi.org\/10.1016\/j.bbrc.2009.03.161","journal-title":"Biochem Biophys Res Commun"},{"key":"10853_CR36","doi-asserted-by":"publisher","first-page":"e36991","DOI":"10.1371\/journal.pone.0036991","volume":"7","author":"M Walmagh","year":"2012","unstructured":"Walmagh M, Briers Y, dos Santos SB, Azeredo J, Lavigne R (2012) Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201\u03c62\u2009\u2013\u20091 and PVP-SE1. PLoS One 7:e36991. https:\/\/doi.org\/10.1371\/journal.pone.0036991","journal-title":"PLoS One"},{"key":"10853_CR37","doi-asserted-by":"publisher","first-page":"14501","DOI":"10.1038\/s41598-017-14797-9","volume":"7","author":"B Maciejewska","year":"2017","unstructured":"Maciejewska B, \u0179rubek K, Espaillat A, Wi\u015bniewska M, Rembacz KP, Cava F, Drulis-Kawa Z (2017) Modular endolysin of Burkholderia AP3 phage has the largest lysozyme-like catalytic subunit discovered to date and no catalytic aspartate residue. Sci Rep 7:14501. https:\/\/doi.org\/10.1038\/s41598-017-14797-9","journal-title":"Sci Rep"},{"key":"10853_CR38","doi-asserted-by":"publisher","DOI":"10.3205\/dgkh000290","volume":"12","author":"M Exner","year":"2017","unstructured":"Exner M, Bhattacharya S, Christiansen B, Gebel J, Goroncy-Bermes P, Hartemann P, Heeg P, Ilschner C, Kramer A, Larson E, Merkens W, Mielke M, Oltmanns P, Ross B, Rotter M, Schmithausen RM, Sonntag HG, Trautmann M (2017) Antibiotic resistance: what is so special about multidrug-resistant Gram-negative bacteria? GMS Hyg Infect Control 12:Doc05. https:\/\/doi.org\/10.3205\/dgkh000290","journal-title":"GMS Hyg Infect Control"},{"key":"10853_CR39","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/jac\/dkg485","volume":"52","author":"I Jado","year":"2003","unstructured":"Jado I, L\u00f3pez R, Garc\u00eda E, Fenoll A, Casal J, Garc\u00eda P (2003) Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. J Antimicrob Chemother 52:967\u2013973. https:\/\/doi.org\/10.1093\/jac\/dkg485","journal-title":"J Antimicrob Chemother"},{"key":"10853_CR40","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/BF03401963","volume":"7","author":"F Zheng","year":"2001","unstructured":"Zheng F, Cai W, Mitsuhashi T, Vlassara H (2001) Lysozyme enhances renal excretion of advanced glycation endproducts in vivo and suppresses adverse age-mediated cellular effects in vitro: a potential AGE sequestration therapy for diabetic nephropathy? Mol Med 7:737\u2013747. https:\/\/doi.org\/10.1007\/BF03401963","journal-title":"Mol Med"},{"key":"10853_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10111277","volume":"10","author":"MU Rahman","year":"2021","unstructured":"Rahman MU, Wang W, Sun Q, Shah JA, Li C, Sun Y, Li Y, Zhang B, Chen W, Wang S (2021) Endolysin, a promising solution against antimicrobial resistance. Antibiotics 10:1277. https:\/\/doi.org\/10.3390\/antibiotics10111277","journal-title":"Antibiotics"},{"key":"10853_CR42","doi-asserted-by":"publisher","first-page":"715039","DOI":"10.3389\/fmicb.2021.715039","volume":"12","author":"S Ryu","year":"2021","unstructured":"Ryu S (2021) Grand challenges in phage biology. Front Microbiol 12:715039. https:\/\/doi.org\/10.3389\/fmicb.2021.715039","journal-title":"Front Microbiol"},{"key":"10853_CR43","unstructured":"GenBank (2024) GenBank and WGS Statistics. https:\/\/www.ncbi.nlm.nih.gov\/genbank\/statistics\/. Accessed 7 Mar 2025"},{"key":"10853_CR44","doi-asserted-by":"publisher","first-page":"W20","DOI":"10.1093\/nar\/gkh435","volume":"32","author":"S McGinnis","year":"2004","unstructured":"McGinnis S, Madden TL (2004) BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Res 32:W20-25. https:\/\/doi.org\/10.1093\/nar\/gkh435","journal-title":"Nucleic Acids Res"},{"key":"10853_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1142\/9781848165632_0019","volume":"23","author":"SR Eddy","year":"2009","unstructured":"Eddy SR (2009) A new generation of homology search tools based on probabilistic inference. Genome Inf 23:205\u2013211. https:\/\/doi.org\/10.1142\/9781848165632_0019","journal-title":"Genome Inf"},{"key":"10853_CR46","doi-asserted-by":"publisher","first-page":"e0032121","DOI":"10.1128\/jvi.00321-21","volume":"95","author":"R V\u00e1zquez","year":"2021","unstructured":"V\u00e1zquez R, Garc\u00eda E, Garc\u00eda P (2021) Sequence-function relationships in phage-encoded bacterial cell wall lytic enzymes and their implications for phage-derived product design. J Virol 95:e0032121. https:\/\/doi.org\/10.1128\/jvi.00321-21","journal-title":"J Virol"},{"key":"10853_CR47","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3390\/v13071240","volume":"13","author":"B Criel","year":"2021","unstructured":"Criel B, Taelman S, Van Criekinge W, Stock M, Briers Y (2021) PhaLP: a database for the study of phage lytic proteins and their evolution. Viruses 13:1240. https:\/\/doi.org\/10.3390\/v13071240","journal-title":"Viruses"},{"key":"10853_CR48","doi-asserted-by":"publisher","first-page":"660403","DOI":"10.3389\/fmicb.2021.660403","volume":"12","author":"R V\u00e1zquez","year":"2021","unstructured":"V\u00e1zquez R, Blanco-Ga\u00f1\u00e1n S, Ruiz S, Garc\u00eda P (2021) Mining of Gram-Negative surface-active enzybiotic candidates by sequence-based calculation of physicochemical properties. Front Microbiol 12:660403. https:\/\/doi.org\/10.3389\/fmicb.2021.660403","journal-title":"Front Microbiol"},{"key":"10853_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065772","volume":"24","author":"H Kim","year":"2023","unstructured":"Kim H, Seo J (2023) A novel strategy to identify endolysins with lytic activity against methicillin-resistant Staphylococcus aureus. Int J Mol Sci 24:5772. https:\/\/doi.org\/10.3390\/ijms24065772","journal-title":"Int J Mol Sci"},{"key":"10853_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz1136","volume":"6","author":"H Gerstmans","year":"2020","unstructured":"Gerstmans H, Grimon D, Guti\u00e9rrez D, Lood C, Rodr\u00edguez A, van Noort V, Lammertyn J, Lavigne R, Briers Y (2020) A VersaTile-driven platform for rapid hit-to-lead development of engineered lysins. Sci Adv 6:eaaz1136. https:\/\/doi.org\/10.1126\/sciadv.aaz1136","journal-title":"Sci Adv"},{"key":"10853_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404049","volume":"11","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li R, Zou G, Guo Y, Wu R, Zhou Y, Chen H, Zhou R, Lavigne R, Bergen PJ, Li J, Li J (2024) Discovery of antimicrobial lysins from the \u201cdark matter\u201d of uncharacterized phages using artificial intelligence. Adv Sci 11:e2404049. https:\/\/doi.org\/10.1002\/advs.202404049","journal-title":"Adv Sci"},{"key":"10853_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114583","volume":"43","author":"Y Fu","year":"2024","unstructured":"Fu Y, Yu S, Li J, Lao Z, Yang X, Lin Z (2024) DeepMineLys: deep mining of phage lysins from human microbiome. Cell Rep 43:114583. https:\/\/doi.org\/10.1016\/j.celrep.2024.114583","journal-title":"Cell Rep"},{"key":"10853_CR53","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00253-016-7928-3","volume":"101","author":"B Maciejewska","year":"2017","unstructured":"Maciejewska B, Roszniowski B, Espaillat A, K\u0119sik-Szeloch A, Majkowska-Skrobek G, Kropinski AM, Briers Y, Cava F, Lavigne R, Drulis-Kawa Z (2017) Klebsiella phages representing a novel clade of viruses with an unknown DNA modification and biotechnologically interesting enzymes. Appl Microbiol Biotechnol 101:673\u2013684. https:\/\/doi.org\/10.1007\/s00253-016-7928-3","journal-title":"Appl Microbiol Biotechnol"},{"key":"10853_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.11.001","volume":"55","author":"VS Gondil","year":"2020","unstructured":"Gondil VS, Harjai K, Chhibber S (2020) Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections. Int J Antimicrob Agents 55:105844. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.11.001","journal-title":"Int J Antimicrob Agents"},{"key":"10853_CR55","doi-asserted-by":"publisher","first-page":"35433","DOI":"10.1074\/jbc.M502723200","volume":"280","author":"LY Low","year":"2005","unstructured":"Low LY, Yang C, Perego M, Osterman A, Liddington RC (2005) Structure and lytic activity of a Bacillus anthracis prophage endolysin. J Biol Chem 280:35433\u201335439. https:\/\/doi.org\/10.1074\/jbc.M502723200","journal-title":"J Biol Chem"},{"key":"10853_CR56","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s00253-006-0771-1","volume":"74","author":"Q Cheng","year":"2007","unstructured":"Cheng Q, Fischetti VA (2007) Mutagenesis of a bacteriophage lytic enzyme PlyGBS significantly increases its antibacterial activity against group B Streptococci. Appl Microbiol Biotechnol 74:1284\u20131291. https:\/\/doi.org\/10.1007\/s00253-006-0771-1","journal-title":"Appl Microbiol Biotechnol"},{"key":"10853_CR57","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1128\/aem.01831-08","volume":"75","author":"M Horgan","year":"2009","unstructured":"Horgan M, O\u2019Flynn G, Garry J, Cooney J, Coffey A, Fitzgerald GF, Ross RP, McAuliffe O (2009) Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant Staphylococci. Appl Environ Microbiol 75:872\u2013874. https:\/\/doi.org\/10.1128\/aem.01831-08","journal-title":"Appl Environ Microbiol"},{"key":"10853_CR58","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4161\/bbug.1.6.13422","volume":"1","author":"M Fenton","year":"2010","unstructured":"Fenton M, Casey PG, Hill C, Gahan CG, Ross RP, McAuliffe O, O\u2019Mahony J, Maher F, Coffey A (2010) The truncated phage lysin CHAP(k) eliminates Staphylococcus aureus in the nares of mice. Bioeng Bugs 1:404\u2013407. https:\/\/doi.org\/10.4161\/bbug.1.6.13422","journal-title":"Bioeng Bugs"},{"key":"10853_CR59","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1128\/jb.00439-11","volume":"193","author":"MJ Mayer","year":"2011","unstructured":"Mayer MJ, Garefalaki V, Spoerl R, Narbad A, Meijers R (2011) Structure-based modification of a Clostridium difficile-targeting endolysin affects activity and host range. J Bacteriol 193:5477\u20135486. https:\/\/doi.org\/10.1128\/jb.00439-11","journal-title":"J Bacteriol"},{"key":"10853_CR60","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1007\/s12033-024-01216-4","volume":"67","author":"M Krishnan","year":"2024","unstructured":"Krishnan M, Tham HY, Wan Nur Ismah W.A.K. K, Yusoff K, Song AA (2024) Effect of domain manipulation in the Staphylococcal phage endolysin, Endo88, on lytic efficiency and host range. Mol Biotechnol 67:2536\u20132544. https:\/\/doi.org\/10.1007\/s12033-024-01216-4","journal-title":"Mol Biotechnol"},{"key":"10853_CR61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1574-6968.2008.01287.x","volume":"287","author":"DM Donovan","year":"2008","unstructured":"Donovan DM, Foster-Frey J (2008) LambdaSa2 prophage endolysin requires Cpl-7-binding domains and amidase-5 domain for antimicrobial lysis of streptococci. FEMS Microbiol Lett 287:22\u201333. https:\/\/doi.org\/10.1111\/j.1574-6968.2008.01287.x","journal-title":"FEMS Microbiol Lett"},{"key":"10853_CR62","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2217\/fmb.12.97","volume":"7","author":"M Schmelcher","year":"2012","unstructured":"Schmelcher M, Donovan DM, Loessner MJ (2012) Bacteriophage endolysins as novel antimicrobials. Future Microbiol 7:1147\u20131171. https:\/\/doi.org\/10.2217\/fmb.12.97","journal-title":"Future Microbiol"},{"key":"10853_CR63","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.1128\/aac.01372-13","volume":"57","author":"R D\u00edez-Mart\u00ednez","year":"2013","unstructured":"D\u00edez-Mart\u00ednez R, de Paz HD, Bustamante N, Garc\u00eda E, Men\u00e9ndez M, Garc\u00eda P (2013) Improving the lethal effect of cpl-7, a pneumococcal phage lysozyme with broad bactericidal activity, by inverting the net charge of its cell wall-binding module. Antimicrob Agents Chemother 57:5355\u20135365. https:\/\/doi.org\/10.1128\/aac.01372-13","journal-title":"Antimicrob Agents Chemother"},{"key":"10853_CR64","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ijantimicag.2011.08.009","volume":"38","author":"G Resch","year":"2011","unstructured":"Resch G, Moreillon P, Fischetti VA (2011) A stable phage lysin (Cpl-1) dimer with increased antipneumococcal activity and decreased plasma clearance. Int J Antimicrob Agents 38:516\u2013521. https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.08.009","journal-title":"Int J Antimicrob Agents"},{"key":"10853_CR65","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/protein\/gzv004","volume":"28","author":"RD Heselpoth","year":"2015","unstructured":"Heselpoth RD, Yin Y, Moult J, Nelson DC (2015) Increasing the stability of the bacteriophage endolysin plyc using rationale-based FoldX computational modeling. Protein Eng Des Sel 28:85\u201392. https:\/\/doi.org\/10.1093\/protein\/gzv004","journal-title":"Protein Eng Des Sel"},{"key":"10853_CR66","doi-asserted-by":"publisher","DOI":"10.3791\/4216","volume":"69","author":"RD Heselpoth","year":"2012","unstructured":"Heselpoth RD, Nelson DC (2012) A new screening method for the directed evolution of thermostable bacteriolytic enzymes. J Vis Exp 69:e4216. https:\/\/doi.org\/10.3791\/4216","journal-title":"J Vis Exp"},{"key":"10853_CR67","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3390\/v13061101","volume":"13","author":"MJ Love","year":"2021","unstructured":"Love MJ, Coombes D, Manners SH, Abeysekera GS, Billington C, Dobson RCJ (2021) The molecular basis for Escherichia coli O157:H7 phage FAHEc1 endolysin function and protein engineering to increase thermal stability. Viruses 13:1101. https:\/\/doi.org\/10.3390\/v13061101","journal-title":"Viruses"},{"key":"10853_CR68","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1021\/acs.biochem.1c00710","volume":"62","author":"JL Tyagi","year":"2023","unstructured":"Tyagi JL, Sharma M, Gulati K, Kairamkonda M, Kumar D, Poluri KM (2023) Engineering of a T7 bacteriophage endolysin variant with enhanced amidase activity. Biochemistry 62:330\u2013344. https:\/\/doi.org\/10.1021\/acs.biochem.1c00710","journal-title":"Biochemistry"},{"key":"10853_CR69","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1093\/molbev\/msw182","volume":"33","author":"A Tripathi","year":"2016","unstructured":"Tripathi A, Gupta K, Khare S, Jain PC, Patel S, Kumar P, Pulianmackal AJ, Aghera N, Varadarajan R (2016) Molecular determinants of mutant phenotypes, inferred from saturation mutagenesis data. Mol Biol Evol 33:2960\u20132975. https:\/\/doi.org\/10.1093\/molbev\/msw182","journal-title":"Mol Biol Evol"},{"key":"10853_CR70","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1046\/j.1365-2958.2003.03684.x","volume":"50","author":"M Zimmer","year":"2003","unstructured":"Zimmer M, Sattelberger E, Inman RB, Calendar R, Loessner MJ (2003) Genome and proteome of Listeria monocytogenes phage PSA: an unusual case for programmed\u2009+\u20091 translational frameshifting in structural protein synthesis. Mol Microbiol 50:303\u2013317. https:\/\/doi.org\/10.1046\/j.1365-2958.2003.03684.x","journal-title":"Mol Microbiol"},{"key":"10853_CR71","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1046\/j.1365-2958.1997.5101880.x","volume":"25","author":"MM Sheehan","year":"1997","unstructured":"Sheehan MM, Garc\u00eda JL, L\u00f3pez R, Garc\u00eda P (1997) The lytic enzyme of the pneumococcal phage Dp-1: a chimeric lysin of intergeneric origin. Mol Microbiol 25:717\u2013725. https:\/\/doi.org\/10.1046\/j.1365-2958.1997.5101880.x","journal-title":"Mol Microbiol"},{"key":"10853_CR72","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1073\/pnas.96.5.2192","volume":"96","author":"RW Hendrix","year":"1999","unstructured":"Hendrix RW, Smith MC, Burns RN, Ford ME, Hatfull GF (1999) Evolutionary relationships among diverse bacteriophages and prophages: all the world\u2019s a phage. Proc Natl Acad Sci U S A 96:2192\u20132197. https:\/\/doi.org\/10.1073\/pnas.96.5.2192","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10853_CR73","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1128\/aem.72.4.2988-2996.2006","volume":"72","author":"DM Donovan","year":"2006","unstructured":"Donovan DM, Dong S, Garrett W, Rousseau GM, Moineau S, Pritchard DG (2006) Peptidoglycan hydrolase fusions maintain their parental specificities. Appl Environ Microbiol 72:2988\u20132996. https:\/\/doi.org\/10.1128\/aem.72.4.2988-2996.2006","journal-title":"Appl Environ Microbiol"},{"key":"10853_CR74","doi-asserted-by":"publisher","first-page":"8125","DOI":"10.1073\/pnas.87.20.8125","volume":"87","author":"E D\u00edaz","year":"1990","unstructured":"D\u00edaz E, L\u00f3pez R, Garc\u00eda JL (1990) Chimeric phage-bacterial enzymes: a clue to the modular evolution of genes. Proc Natl Acad Sci U S A 87:8125\u20138129. https:\/\/doi.org\/10.1073\/pnas.87.20.8125","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10853_CR75","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.1016\/S0021-9258(19)67618-0","volume":"266","author":"E Diaz","year":"1991","unstructured":"Diaz E, L\u00f3pez R, Garcia JL (1991) Chimeric pneumococcal cell wall lytic enzymes reveal important physiological and evolutionary traits. J Biol Chem 266:5464\u20135471. https:\/\/doi.org\/10.1016\/S0021-9258(19)67618-0","journal-title":"J Biol Chem"},{"key":"10853_CR76","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1365-2958.1993.tb01231.x","volume":"9","author":"C Croux","year":"1993","unstructured":"Croux C, Ronda C, L\u00f3pez R, Garc\u00eda JL (1993) Interchange of functional domains switches enzyme specificity: construction of a chimeric pneumococcal-clostridial cell wall lytic enzyme. Mol Microbiol 9:1019\u20131025. https:\/\/doi.org\/10.1111\/j.1365-2958.1993.tb01231.x","journal-title":"Mol Microbiol"},{"key":"10853_CR77","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1432-1033.1996.00601.x","volume":"235","author":"JM Sanz","year":"1996","unstructured":"Sanz JM, Garc\u00eda P, Garc\u00eda JL (1996) Construction of a multifunctional pneumococcal murein hydrolase by module assembly. Eur J Biochem 235:601\u2013605. https:\/\/doi.org\/10.1111\/j.1432-1033.1996.00601.x","journal-title":"Eur J Biochem"},{"key":"10853_CR78","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.3390\/v7062758","volume":"7","author":"SM Swift","year":"2015","unstructured":"Swift SM, Seal BS, Garrish JK, Oakley BB, Hiett K, Yeh HY, Woolsey R, Schegg KM, Line JE, Donovan DM (2015) A thermophilic phage endolysin fusion to a Clostridium perfringens-specific cell wall binding domain creates an anti-Clostridium antimicrobial with improved thermostability. Viruses 7:3019\u20133034. https:\/\/doi.org\/10.3390\/v7062758","journal-title":"Viruses"},{"key":"10853_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.615887","volume":"11","author":"B Son","year":"2020","unstructured":"Son B, Kong M, Lee Y, Ryu S (2020) Development of a novel chimeric endolysin, Lys109 with enhanced lytic activity against Staphylococcus aureus. Front Microbiol 11:615887. https:\/\/doi.org\/10.3389\/fmicb.2020.615887","journal-title":"Front Microbiol"},{"key":"10853_CR80","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1021\/acsinfecdis.0c00812","volume":"7","author":"C Lee","year":"2021","unstructured":"Lee C, Kim J, Son B, Ryu S (2021) Development of advanced chimeric endolysin to control multidrug-resistant Staphylococcus aureus through domain shuffling. ACS Infect Dis 7:2081\u20132092. https:\/\/doi.org\/10.1021\/acsinfecdis.0c00812","journal-title":"ACS Infect Dis"},{"key":"10853_CR81","doi-asserted-by":"publisher","first-page":"127969","DOI":"10.1016\/j.ijbiomac.2023.127969","volume":"254","author":"M Behera","year":"2024","unstructured":"Behera M, Singh G, Vats A, Parmanand RM, Gautam D, Rana C, Kesharwani RK, De S, Ghorai SM (2024) Expression and characterization of novel chimeric endolysin CHAPk-SH3bk against biofilm-forming methicillin-resistant Staphylococcus aureus. Int J Biol Macromol 254:127969. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.127969","journal-title":"Int J Biol Macromol"},{"key":"10853_CR82","doi-asserted-by":"publisher","first-page":"e0254023","DOI":"10.1128\/mbio.02540-23","volume":"15","author":"C Roehrig","year":"2024","unstructured":"Roehrig C, Huemer M, Lorg\u00e9 D, Arn F, Heinrich N, Selvakumar L, Gasser L, Hauswirth P, Chang CC, Schweizer TA, Eichenseher F, Lehmann S, Zinkernagel AS, Schmelcher M (2024) MEndoB, a chimeric lysin featuring a novel domain architecture and superior activity for the treatment of Staphylococcal infections. mBio 15:e0254023. https:\/\/doi.org\/10.1128\/mbio.02540-23","journal-title":"mBio"},{"key":"10853_CR83","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3390\/ph3041139","volume":"3","author":"MD Bastos","year":"2010","unstructured":"Bastos MD, Coutinho BG, Coelho ML (2010) Lysostaphin: a Staphylococcal bacteriolysin with potential clinical applications. Pharmaceuticals (Basel) 3:1139\u20131161. https:\/\/doi.org\/10.3390\/ph3041139","journal-title":"Pharmaceuticals (Basel)"},{"key":"10853_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-12-41","author":"AA Vipra","year":"2012","unstructured":"Vipra AA, Desai SN, Roy P, Patil R, Raj JM, Narasimhaswamy N, Paul VD, Chikkamadaiah R, Sriram B (2012) Antistaphylococcal activity of bacteriophage derived chimeric protein P128. BMC Microbiol. https:\/\/doi.org\/10.1186\/1471-2180-12-41","journal-title":"BMC Microbiol"},{"key":"10853_CR85","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02724-16","volume":"61","author":"L Fern\u00e1ndez","year":"2017","unstructured":"Fern\u00e1ndez L, Gonz\u00e1lez S, Campelo AB, Mart\u00ednez B, Rodr\u00edguez A, Garc\u00eda P (2017) Downregulation of autolysin-encoding genes by phage-derived lytic proteins inhibits biofilm formation in Staphylococcus aureus. Antimicrob Agents Chemother 61:10.1128\/aac.02724\u2009\u2212\u200902716. https:\/\/doi.org\/10.1128\/aac.02724-16","journal-title":"Antimicrob Agents Chemother"},{"key":"10853_CR86","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1128\/aem.07621-11","volume":"78","author":"L Rodr\u00edguez-Rubio","year":"2012","unstructured":"Rodr\u00edguez-Rubio L, Mart\u00ednez B, Donovan Rodr\u00edguezA, Garc\u00eda P (2012) Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 HydH5 virion-associated peptidoglycan hydrolase: fusions, deletions, and synergy with LysH5. Appl Environ Microbiol 78:2241\u20132248. https:\/\/doi.org\/10.1128\/aem.07621-11","journal-title":"Appl Environ Microbiol"},{"key":"10853_CR87","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02273-21","volume":"66","author":"F Eichenseher","year":"2022","unstructured":"Eichenseher F, Herpers BL, Badoux P, Leyva-Castillo JM, Geha RS, van der Zwart M, McKellar J, Janssen F, de Rooij B, Selvakumar L, R\u00f6hrig C, Frieling J, Offerhaus M, Loessner MJ, Schmelcher M (2022) Linker-improved chimeric endolysin selectively kills Staphylococcus aureus in vitro, on reconstituted human epidermis, and in a murine model of skin infection. Antimicrob Agents Chemother 66:e0227321. https:\/\/doi.org\/10.1128\/aac.02273-21","journal-title":"Antimicrob Agents Chemother"},{"key":"10853_CR88","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000473872","volume":"9","author":"JEE Tott\u00e9","year":"2017","unstructured":"Tott\u00e9 JEE, van Doorn MB, Pasmans S (2017) Successful treatment of chronic Staphylococcus aureus-related dermatoses with the topical endolysin Staphefekt SA.100: a report of 3 cases. Case Rep Dermatol 9:19\u201325. https:\/\/doi.org\/10.1159\/000473872","journal-title":"Case Rep Dermatol"},{"key":"10853_CR89","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/b93995","volume":"89","author":"B Fahnert","year":"2004","unstructured":"Fahnert B, Lilie H, Neubauer P (2004) Inclusion bodies: formation and utilisation. Adv Biochem Eng Biotechnol 89:93\u2013142. https:\/\/doi.org\/10.1007\/b93995","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"10853_CR90","unstructured":"Organization WH (2017) WHO publishes list of bacteria for which new antibiotics are urgently needed. https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Accessed 2 Feb 2025"},{"key":"10853_CR91","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","volume":"22","author":"WR Miller","year":"2024","unstructured":"Miller WR, Arias CA (2024) ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics. Nat Rev Microbiol 22:598\u2013616. https:\/\/doi.org\/10.1038\/s41579-024-01054-w","journal-title":"Nat Rev Microbiol"},{"key":"10853_CR92","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/mbo3.187","volume":"3","author":"R Cavaliere","year":"2014","unstructured":"Cavaliere R, Ball JL, Turnbull L, Whitchurch CB (2014) The biofilm matrix destabilizers, EDTA and DNaseI, enhance the susceptibility of nontypeable Hemophilus influenzae biofilms to treatment with ampicillin and ciprofloxacin. Microbiologyopen 3:557\u2013567. https:\/\/doi.org\/10.1002\/mbo3.187","journal-title":"Microbiologyopen"},{"key":"10853_CR93","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1111\/jam.15661","volume":"133","author":"T Nie","year":"2022","unstructured":"Nie T, Meng F, Lu F, Bie X, Zhao H, Sun J, Lu Z, Lu Y (2022) An endolysin Salmcide-p1 from bacteriophage fmb-p1 against gram-negative bacteria. J Appl Microbiol 133:1597\u20131609. https:\/\/doi.org\/10.1111\/jam.15661","journal-title":"J Appl Microbiol"},{"key":"10853_CR94","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.1007\/s00253-021-11366-z","volume":"105","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Xu D, Wang L, Qu M, Li F, Tan Z, Yao L (2021) Characterization of a broad-spectrum endolysin LysSP1 encoded by a Salmonella bacteriophage. Appl Microbiol Biotechnol 105:5461\u20135470. https:\/\/doi.org\/10.1007\/s00253-021-11366-z","journal-title":"Appl Microbiol Biotechnol"},{"key":"10853_CR95","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1574-6968.2007.01051.x","volume":"280","author":"Y Briers","year":"2008","unstructured":"Briers Y, Cornelissen A, Aertsen A, Hertveldt K, Michiels CW, Volckaert G, Lavigne R (2008) Analysis of outer membrane permeability of Pseudomonas aeruginosa and bactericidal activity of endolysins KZ144 and EL188 under high hydrostatic pressure. FEMS Microbiol Lett 280:113\u2013119. https:\/\/doi.org\/10.1111\/j.1574-6968.2007.01051.x","journal-title":"FEMS Microbiol Lett"},{"key":"10853_CR96","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1111\/bph.13706","volume":"174","author":"G Hughes","year":"2017","unstructured":"Hughes G, Webber MA (2017) Novel approaches to the treatment of bacterial biofilm infections. Br J Pharmacol 174:2237\u20132246. https:\/\/doi.org\/10.1111\/bph.13706","journal-title":"Br J Pharmacol"},{"key":"10853_CR97","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fmicb.2016.00208","volume":"7","author":"H Oliveira","year":"2016","unstructured":"Oliveira H, Vilas Boas D, Mesnage S, Kluskens LD, Lavigne R, Sillankorva S, Secundo F, Azeredo J (2016) Structural and enzymatic characterization of ABgp46, a novel phage endolysin with broad anti-Gram-Negative bacterial activity. Front Microbiol 7:208. https:\/\/doi.org\/10.3389\/fmicb.2016.00208","journal-title":"Front Microbiol"},{"key":"10853_CR98","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3390\/molecules23061399","volume":"23","author":"S Garc\u00eda-Salinas","year":"2018","unstructured":"Garc\u00eda-Salinas S, Elizondo-Castillo H, Arruebo M, Mendoza G, Irusta S (2018) Evaluation of the antimicrobial activity and cytotoxicity of different components of natural origin present in essential oils. Molecules 23:1399. https:\/\/doi.org\/10.3390\/molecules23061399","journal-title":"Molecules"},{"key":"10853_CR99","doi-asserted-by":"publisher","first-page":"110187","DOI":"10.1016\/j.foodcont.2023.110187","volume":"157","author":"K Junhwan","year":"2024","unstructured":"Junhwan K, Song-Rae K, Jun W, Juhee A (2024) Synergistic antimicrobial activity of essential oils in combination with phage endolysin against Salmonella typhimurium in cooked ground beef. Food Control 157:110187. https:\/\/doi.org\/10.1016\/j.foodcont.2023.110187","journal-title":"Food Control"},{"key":"10853_CR100","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3389\/fmicb.2016.01402","volume":"7","author":"R Thummeepak","year":"2016","unstructured":"Thummeepak R, Kitti T, Kunthalert D, Sitthisak S (2016) Enhanced antibacterial activity of Acinetobacter baumannii bacteriophage \u00d8ABP-01 endolysin (LysABP-01) in combination with colistin. Front Microbiol 7:1402. https:\/\/doi.org\/10.3389\/fmicb.2016.01402","journal-title":"Front Microbiol"},{"key":"10853_CR101","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3390\/ijms23031873","volume":"23","author":"S Quintana-Sanchez","year":"2022","unstructured":"Quintana-Sanchez S, G\u00f3mez-Casanova N, S\u00e1nchez-Nieves J, G\u00f3mez R, Rachuna J, W\u0105sik S, Semaniak J, Maciejewska B, Drulis-Kawa Z, Ciepluch K, Mata FJ, Arabski M (2022) The antibacterial effect of pegylated carbosilane dendrimers on P. aeruginosa alone and in combination with Phage-Derived endolysin. Int J Mol Sci 23:1873. https:\/\/doi.org\/10.3390\/ijms23031873","journal-title":"Int J Mol Sci"},{"key":"10853_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.134634","volume":"278","author":"K Lach","year":"2024","unstructured":"Lach K, Skrzyniarz K, Takvor-Mena S, \u0141ysek-G\u0142adysi\u0144ska M, Furma\u0144czyk P, Barrios-Gumiel O, Sanchez-Nieves J, Ciepluch K (2024) Endolysin CHAP domain-carbosilane metallodendrimer complexes with triple action on Gram-negative bacteria: membrane destabilization, reactive oxygen species production and peptidoglycan degradation. Int J Biol Macromol 278:134634. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134634","journal-title":"Int J Biol Macromol"},{"key":"10853_CR103","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/s00253-013-5128-y","volume":"98","author":"T Gervasi","year":"2014","unstructured":"Gervasi T, Horn N, Wegmann U, Dugo G, Narbad A, Mayer MJ (2014) Expression and delivery of an endolysin to combat Clostridium perfringens. Appl Microbiol Biotechnol 98:2495\u20132505. https:\/\/doi.org\/10.1007\/s00253-013-5128-y","journal-title":"Appl Microbiol Biotechnol"},{"key":"10853_CR104","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.bbamem.2006.03.021","volume":"1758","author":"I Zelezetsky","year":"2006","unstructured":"Zelezetsky I, Tossi A (2006) Alpha-helical antimicrobial peptides\u2013using a sequence template to guide structure-activity relationship studies. Biochim Biophys Acta 1758:1436\u20131449. https:\/\/doi.org\/10.1016\/j.bbamem.2006.03.021","journal-title":"Biochim Biophys Acta"},{"key":"10853_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11101448","volume":"11","author":"R V\u00e1zquez","year":"2022","unstructured":"V\u00e1zquez R, Dom\u00e9nech-S\u00e1nchez A, Ruiz S, Sempere J, Yuste J, Albert\u00ed S, Garc\u00eda P (2022) Improvement of the antibacterial activity of phage lysin-derived peptide P87 through maximization of physicochemical properties and assessment of its therapeutic potential. Antibiotics (Basel) 11:1448. https:\/\/doi.org\/10.3390\/antibiotics11101448","journal-title":"Antibiotics (Basel)"},{"key":"10853_CR106","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0003-2697(88)90134-0","volume":"171","author":"R Zhou","year":"1988","unstructured":"Zhou R, Chen S, Recsei P (1988) A dye release assay for determination of lysostaphin activity. Anal Biochem 171:141\u2013144. https:\/\/doi.org\/10.1016\/0003-2697(88)90134-0","journal-title":"Anal Biochem"},{"key":"10853_CR107","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01379-14","volume":"5","author":"Y Briers","year":"2014","unstructured":"Briers Y, Walmagh M, Van Puyenbroeck V, Cornelissen A, Cenens W, Aertsen A, Oliveira H, Azeredo J, Verween G, Pirnay JP, Miller S, Volckaert G, Lavigne R (2014) Engineered endolysin-based \u201cArtilysins\u201d to combat multidrug-resistant gram-negative pathogens. mBio 5:e01379-01314. https:\/\/doi.org\/10.1128\/mBio.01379-14","journal-title":"mBio"},{"key":"10853_CR108","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.2478\/s11756-020-00508-9","volume":"75","author":"M Michaela","year":"2020","unstructured":"Michaela M, Zuzana \u0160, Darina P, Andrej G (2020) Functional expression and purification of tailor-made chimeric endolysin with the broad antibacterial spectrum. Biol 75:2031\u20132043. https:\/\/doi.org\/10.2478\/s11756-020-00508-9","journal-title":"Biol"},{"key":"10853_CR109","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12929-024-01027-4","volume":"31","author":"J Lim","year":"2024","unstructured":"Lim J, Myung H, Lim D, Song M (2024) Antimicrobial peptide Thanatin fused endolysin PA90 (Tha-PA90) for the control of Acinetobacter baumannii infection in mouse model. J Biomed Sci 31:36. https:\/\/doi.org\/10.1186\/s12929-024-01027-4","journal-title":"J Biomed Sci"},{"key":"10853_CR110","doi-asserted-by":"publisher","first-page":"7470","DOI":"10.1038\/s41598-023-33822-8","volume":"13","author":"S Sitthisak","year":"2023","unstructured":"Sitthisak S, Manrueang S, Khongfak S, Leungtongkam U, Thummeepak R, Thanwisai A, Burton N, Dhanoa GK, Tsapras P, Sagona AP (2023) Antibacterial activity of vB_AbaM_PhT2 phage hydrophobic amino acid fusion endolysin, combined with colistin against Acinetobacter baumannii. Sci Rep 13:7470. https:\/\/doi.org\/10.1038\/s41598-023-33822-8","journal-title":"Sci Rep"},{"key":"10853_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/s13568-021-01222-8","volume":"11","author":"D Xu","year":"2021","unstructured":"Xu D, Zhao S, Dou J, Xu X, Zhi Y, Wen L (2021) Engineered endolysin-based \u201cartilysins\u201d for controlling the gram-negative pathogen Helicobacter pylori. AMB Express 11:63. https:\/\/doi.org\/10.1186\/s13568-021-01222-8","journal-title":"AMB Express"},{"key":"10853_CR112","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1021\/acsinfecdis.1c00222","volume":"7","author":"X Chen","year":"2021","unstructured":"Chen X, Liu M, Zhang P, Leung SSY, Xia J (2021) Membrane-permeable antibacterial enzyme against multidrug-resistant Acinetobacter baumannii. ACS Infect Dis 7:2192\u20132204. https:\/\/doi.org\/10.1021\/acsinfecdis.1c00222","journal-title":"ACS Infect Dis"},{"key":"10853_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.129493","volume":"260","author":"J Cho","year":"2024","unstructured":"Cho J, Hong HW, Park K, Myung H, Yoon H (2024) Unveiling the mechanism of bactericidal activity of a cecropin A-fused endolysin LNT113. Int J Biol Macromol 260:129493. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129493","journal-title":"Int J Biol Macromol"},{"key":"10853_CR114","doi-asserted-by":"publisher","first-page":"14937","DOI":"10.1021\/acs.jmedchem.0c01506","volume":"63","author":"S Hyun","year":"2020","unstructured":"Hyun S, Choi Y, Jo D, Choo S, Park TW, Park SJ, Kim S, Lee S, Park S, Jin SM, Cheon DH, Yoo W, Arya R, Chong YP, Kim KK, Kim YS, Lee Y, Yu J (2020) Proline hinged amphipathic \u03b1-helical peptide sensitizes Gram-Negative bacteria to various Gram-Positive antibiotics. J Med Chem 63:14937\u201314950. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01506","journal-title":"J Med Chem"},{"key":"10853_CR115","doi-asserted-by":"publisher","first-page":"1296796","DOI":"10.3389\/fmicb.2023.1296796","volume":"14","author":"SM Son","year":"2023","unstructured":"Son SM, Kim J, Ryu S (2023) Development of sensitizer peptide-fused endolysin Lys1S-L9P acting against multidrug-resistant gram-negative bacteria. Front Microbiol 14:1296796. https:\/\/doi.org\/10.3389\/fmicb.2023.1296796","journal-title":"Front Microbiol"},{"key":"10853_CR116","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/exd.13314","volume":"26","author":"F Niyonsaba","year":"2017","unstructured":"Niyonsaba F, Kiatsurayanon C, Chieosilapatham P, Ogawa H (2017) Friends or foes? Host defense (antimicrobial) peptides and proteins in human skin diseases. Exp Dermatol 26:989\u2013998. https:\/\/doi.org\/10.1111\/exd.13314","journal-title":"Exp Dermatol"},{"key":"10853_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2023.108250","volume":"69","author":"JV Carratal\u00e1","year":"2023","unstructured":"Carratal\u00e1 JV, Ar\u00eds A, Garcia-Fruit\u00f3s E, Ferrer-Miralles N (2023) Design strategies for positively charged endolysins: insights into Artilysin development. Biotechnol Adv 69:108250. https:\/\/doi.org\/10.1016\/j.biotechadv.2023.108250","journal-title":"Biotechnol Adv"},{"key":"10853_CR118","doi-asserted-by":"publisher","first-page":"12087","DOI":"10.1038\/s41598-020-68983-3","volume":"10","author":"A Zampara","year":"2020","unstructured":"Zampara A, S\u00f8rensen MCH, Grimon D, Antenucci F, Vitt AR, Bortolaia V, Briers Y, Br\u00f8ndsted L (2020) Exploiting phage receptor binding proteins to enable endolysins to kill Gram-negative bacteria. Sci Rep 10:12087. https:\/\/doi.org\/10.1038\/s41598-020-68983-3","journal-title":"Sci Rep"},{"key":"10853_CR119","doi-asserted-by":"publisher","first-page":"619028","DOI":"10.3389\/fmicb.2021.619028","volume":"12","author":"A Zampara","year":"2021","unstructured":"Zampara A, S\u00f8rensen MCH, Gencay YE, Grimon D, Kristiansen SH, J\u00f8rgensen LS, Kristensen JR, Briers Y, Elsser-Gravesen A, Br\u00f8ndsted L (2021) Developing innolysins against Campylobacter jejuni using a novel prophage Receptor-Binding protein. Front Microbiol 12:619028. https:\/\/doi.org\/10.3389\/fmicb.2021.619028","journal-title":"Front Microbiol"},{"key":"10853_CR120","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00342-19","volume":"63","author":"RD Heselpoth","year":"2019","unstructured":"Heselpoth RD, Euler CW, Schuch R, Fischetti VA (2019) Lysocins: bioengineered antimicrobials that deliver lysins across the outer membrane of gram-negative bacteria. Antimicrob Agents Chemother 63:10.1128\/aac.00342\u2009\u2212\u200900319. https:\/\/doi.org\/10.1128\/aac.00342-19","journal-title":"Antimicrob Agents Chemother"},{"key":"10853_CR121","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1042\/bcj20160470","volume":"473","author":"LC McCaughey","year":"2016","unstructured":"McCaughey LC, Josts I, Grinter R, White P, Byron O, Tucker NP, Matthews JM, Kleanthous C, Whitchurch CB, Walker D (2016) Discovery, characterization and in vivo activity of pyocin SD2, a protein antibiotic from Pseudomonas aeruginosa. Biochem J 473:2345\u20132358. https:\/\/doi.org\/10.1042\/bcj20160470","journal-title":"Biochem J"},{"key":"10853_CR122","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1128\/mmbr.00036-06","volume":"71","author":"E Cascales","year":"2007","unstructured":"Cascales E, Buchanan SK, Duch\u00e9 D, Kleanthous C, Lloub\u00e8s R, Postle K, Riley M, Slatin S, Cavard D (2007) Colicin biology. Microbiol Mol Biol Rev 71:158\u2013229. https:\/\/doi.org\/10.1128\/mmbr.00036-06","journal-title":"Microbiol Mol Biol Rev"},{"key":"10853_CR123","doi-asserted-by":"publisher","first-page":"9857","DOI":"10.1073\/pnas.1203472109","volume":"109","author":"P Lukacik","year":"2012","unstructured":"Lukacik P, Barnard TJ, Keller PW, Chaturvedi KS, Seddiki N, Fairman JW, Noinaj N, Kirby TL, Henderson JP, Steven AC, Hinnebusch BJ, Buchanan SK (2012) Structural engineering of a phage lysin that targets gram-negative pathogens. Proc Natl Acad Sci U S A 109:9857\u20139862. https:\/\/doi.org\/10.1073\/pnas.1203472109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10853_CR124","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s10482-017-0912-9","volume":"110","author":"G Yan","year":"2017","unstructured":"Yan G, Liu J, Ma Q, Zhu R, Guo Z, Gao C, Wang S, Yu L, Gu J, Hu D, Han W, Du R, Yang J, Lei L (2017) The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularly. Antonie Van Leeuwenhoek 110:1627\u20131635. https:\/\/doi.org\/10.1007\/s10482-017-0912-9","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10853_CR125","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuab019","volume":"45","author":"AM Pinto","year":"2021","unstructured":"Pinto AM, Silva MD, Pastrana LM, Ba\u00f1obre-L\u00f3pez M, Sillankorva S (2021) The clinical path to deliver encapsulated phages and lysins. FEMS Microbiol Rev 45:fuab019. https:\/\/doi.org\/10.1093\/femsre\/fuab019","journal-title":"FEMS Microbiol Rev"},{"key":"10853_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/v10110638","volume":"10","author":"M Harhala","year":"2018","unstructured":"Harhala M, Nelson DC, Miernikiewicz P, Heselpoth RD, Brzezicka B, Majewska J, Linden SB, Shang X, Szymczak A, Lecion D, Marek-Bukowiec K, K\u0142ak M, Wojciechowicz B, Lahutta K, Konieczny A, D\u0105browska K (2018) Safety studies of Pneumococca l endolysins Cpl-1 and Pal. Viruses 10:638. https:\/\/doi.org\/10.3390\/v10110638","journal-title":"Viruses"},{"key":"10853_CR127","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/1040841x.2020.1809346","volume":"46","author":"V De Maesschalck","year":"2020","unstructured":"De Maesschalck V, Guti\u00e9rrez D, Paeshuyse J, Lavigne R, Briers Y (2020) Advanced engineering of third-generation lysins and formulation strategies for clinical applications. Crit Rev Microbiol 46:548\u2013564. https:\/\/doi.org\/10.1080\/1040841x.2020.1809346","journal-title":"Crit Rev Microbiol"},{"key":"10853_CR128","doi-asserted-by":"publisher","first-page":"2387144","DOI":"10.1080\/19490976.2024.2387144","volume":"16","author":"I Pottie","year":"2024","unstructured":"Pottie I, V\u00e1zquez Fern\u00e1ndez R, Van de Wiele T, Briers Y (2024) Phage lysins for intestinal microbiome modulation: current challenges and enabling techniques. Gut Microbes 16:2387144. https:\/\/doi.org\/10.1080\/19490976.2024.2387144","journal-title":"Gut Microbes"},{"key":"10853_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2020.117108","volume":"251","author":"S Rashki","year":"2021","unstructured":"Rashki S, Asgarpour K, Tarrahimofrad H, Hashemipour M, Ebrahimi MS, Fathizadeh H, Khorshidi A, Khan H, Marzhoseyni Z, Salavati-Niasari M, Mirzaei H (2021) Chitosan-based nanoparticles against bacterial infections. Carbohydr Polym 251:117108. https:\/\/doi.org\/10.1016\/j.carbpol.2020.117108","journal-title":"Carbohydr Polym"},{"key":"10853_CR130","doi-asserted-by":"publisher","first-page":"8572","DOI":"10.1039\/c8cs00162f","volume":"47","author":"E Rideau","year":"2018","unstructured":"Rideau E, Dimova R, Schwille P, Wurm FR, Landfester K (2018) Liposomes and polymersomes: a comparative review towards cell mimicking. Chem Soc Rev 47:8572\u20138610. https:\/\/doi.org\/10.1039\/c8cs00162f","journal-title":"Chem Soc Rev"},{"key":"10853_CR131","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1021\/acsinfecdis.1c00108","volume":"7","author":"MD Silva","year":"2021","unstructured":"Silva MD, Paris JL, Gama FM, Silva BFB, Sillankorva S (2021) Sustained release of a Streptococcus pneumoniae endolysin from liposomes for potential otitis media treatment. ACS Infect Dis 7:2127\u20132137. https:\/\/doi.org\/10.1021\/acsinfecdis.1c00108","journal-title":"ACS Infect Dis"},{"key":"10853_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9050242","volume":"9","author":"S Portilla","year":"2020","unstructured":"Portilla S, Fern\u00e1ndez L, Guti\u00e9rrez D, Rodr\u00edguez A, Garc\u00eda P (2020) Encapsulation of the Antistaphylococcal endolysin LysRODI in pH-sensitive liposomes. Antibiotics 9:242. https:\/\/doi.org\/10.3390\/antibiotics9050242","journal-title":"Antibiotics"},{"key":"10853_CR133","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.enzmictec.2019.05.006","volume":"128","author":"J Bai","year":"2019","unstructured":"Bai J, Yang E, Chang PS, Ryu S (2019) Preparation and characterization of endolysin-containing liposomes and evaluation of their antimicrobial activities against gram-negative bacteria. Enzyme Microb Technol 128:40\u201348. https:\/\/doi.org\/10.1016\/j.enzmictec.2019.05.006","journal-title":"Enzyme Microb Technol"},{"key":"10853_CR134","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.addr.2020.07.002","volume":"154","author":"S Shah","year":"2020","unstructured":"Shah S, Dhawan V, Holm R, Nagarsenker MS, Perrie Y (2020) Liposomes: advancements and innovation in the manufacturing process. Adv Drug Deliv Rev 154:102\u2013122. https:\/\/doi.org\/10.1016\/j.addr.2020.07.002","journal-title":"Adv Drug Deliv Rev"},{"key":"10853_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120571","volume":"601","author":"D Guimar\u00e3es","year":"2021","unstructured":"Guimar\u00e3es D, Cavaco-Paulo A, Nogueira E (2021) Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm 601:120571. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120571","journal-title":"Int J Pharm"},{"key":"10853_CR136","doi-asserted-by":"publisher","first-page":"10979","DOI":"10.1021\/acsnano.3c11154","volume":"18","author":"G Liang","year":"2024","unstructured":"Liang G, Cao W, Tang D, Zhang H, Yu Y, Ding J, Karges J, Xiao H (2024) Nanomedomics. ACS Nano 18:10979\u201311024. https:\/\/doi.org\/10.1021\/acsnano.3c11154","journal-title":"ACS Nano"},{"key":"10853_CR137","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jconrel.2016.11.030","volume":"245","author":"H Hathaway","year":"2017","unstructured":"Hathaway H, Ajuebor J, Stephens L, Coffey A, Potter U, Sutton JM, Jenkins AT (2017) Thermally triggered release of the bacteriophage endolysin CHAP(K) and the bacteriocin lysostaphin for the control of methicillin resistant Staphylococcus aureus (MRSA). J Control Release 245:108\u2013115. https:\/\/doi.org\/10.1016\/j.jconrel.2016.11.030","journal-title":"J Control Release"},{"key":"10853_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118605","volume":"273","author":"R V\u00e1zquez","year":"2021","unstructured":"V\u00e1zquez R, Caro-Le\u00f3n FJ, Nakal A, Ruiz S, Do\u00f1oro C, Garc\u00eda-Fern\u00e1ndez L, V\u00e1zquez-Lasa B, San Rom\u00e1n J, Sanz J, Garc\u00eda P, Aguilar MR (2021) DEAE-chitosan nanoparticles as a pneumococcus-biomimetic material for the development of antipneumococcal therapeutics. Carbohydr Polym 273:118605. https:\/\/doi.org\/10.1016\/j.carbpol.2021.118605","journal-title":"Carbohydr Polym"},{"key":"10853_CR139","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1007\/s12010-023-04627-2","volume":"196","author":"B Liu","year":"2024","unstructured":"Liu B, Li Z, Guo Q, Guo X, Liu R, Liu X (2024) Integration of lysin into chitosan nanoparticles for improving bacterial biofilm inhibition. Appl Biochem Biotechnol 196:1592\u20131611. https:\/\/doi.org\/10.1007\/s12010-023-04627-2","journal-title":"Appl Biochem Biotechnol"},{"key":"10853_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.biortech.2020.124653","volume":"325","author":"PK Obulisamy","year":"2021","unstructured":"Obulisamy PK, Mehariya S (2021) Polyhydroxyalkanoates from extremophiles: a review. Bioresour Technol 325:124653. https:\/\/doi.org\/10.1016\/j.biortech.2020.124653","journal-title":"Bioresour Technol"},{"key":"10853_CR141","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.molmed.2022.01.007","volume":"28","author":"DA Gregory","year":"2022","unstructured":"Gregory DA, Taylor CS, Fricker ATR, Asare E, Tetali SSV, Haycock JW, Roy I (2022) Polyhydroxyalkanoates and their advances for biomedical applications. Trends Mol Med 28:331\u2013342. https:\/\/doi.org\/10.1016\/j.molmed.2022.01.007","journal-title":"Trends Mol Med"},{"key":"10853_CR142","doi-asserted-by":"publisher","first-page":"562748","DOI":"10.3389\/fmicb.2021.562748","volume":"12","author":"CG Davies","year":"2021","unstructured":"Davies CG, Reilly K, Altermann E, Hendrickson HL (2021) PLAN-M; mycobacteriophage endolysins fused to biodegradable nanobeads mitigate mycobacterial growth in liquid and on surfaces. Front Microbiol 12:562748. https:\/\/doi.org\/10.3389\/fmicb.2021.562748","journal-title":"Front Microbiol"},{"key":"10853_CR143","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3390\/foods11060854","volume":"11","author":"E Stone","year":"2022","unstructured":"Stone E, Pennone V, Reilly K, Grant IR, Campbell K, Altermann E, McAuliffe O (2022) Inhibition of Listeria monocytogenes by phage lytic enzymes displayed on tailored bionanoparticles. Foods 11:854. https:\/\/doi.org\/10.3390\/foods11060854","journal-title":"Foods"},{"key":"10853_CR144","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.addr.2021.04.024","volume":"174","author":"C Karavasili","year":"2021","unstructured":"Karavasili C, Fatouros DG (2021) Self-assembling peptides as vectors for local drug delivery and tissue engineering applications. Adv Drug Deliv Rev 174:387\u2013405. https:\/\/doi.org\/10.1016\/j.addr.2021.04.024","journal-title":"Adv Drug Deliv Rev"},{"key":"10853_CR145","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.addr.2016.08.006","volume":"110\u2013111","author":"H Acar","year":"2017","unstructured":"Acar H, Srivastava S, Chung EJ, Schnorenberg MR, Barrett JC, LaBelle JL, Tirrell M (2017) Self-assembling peptide-based building blocks in medical applications. Adv Drug Deliv Rev 110\u2013111:65\u201379. https:\/\/doi.org\/10.1016\/j.addr.2016.08.006","journal-title":"Adv Drug Deliv Rev"},{"key":"10853_CR146","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1021\/acsabm.2c00741","volume":"5","author":"CKO Dzuvor","year":"2022","unstructured":"Dzuvor CKO, Shanbhag BK, Younas T, Shen HH, Haritos VS, He L (2022) Engineering self-assembled endolysin nanoparticles against antibiotic-resistant bacteria. ACS Appl Bio Mater 5:4993\u20135003. https:\/\/doi.org\/10.1021\/acsabm.2c00741","journal-title":"ACS Appl Bio Mater"},{"key":"10853_CR147","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s12010-023-04514-w","volume":"196","author":"M Malekian","year":"2024","unstructured":"Malekian M, Fahimi H, Niri NM, Khaleghi S (2024) Development of novel chimeric endolysin conjugated with Chitosan-Zn-Metal-Organic framework nanocomposites with antibacterial activity. Appl Biochem Biotechnol 196:616\u2013631. https:\/\/doi.org\/10.1007\/s12010-023-04514-w","journal-title":"Appl Biochem Biotechnol"},{"key":"10853_CR148","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201606134","volume":"29","author":"MX Wu","year":"2017","unstructured":"Wu MX, Yang YW (2017) Metal-Organic framework (MOF)-based drug\/cargo delivery and cancer therapy. Adv Mater 29:1606134. https:\/\/doi.org\/10.1002\/adma.201606134","journal-title":"Adv Mater"},{"key":"10853_CR149","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202104843","volume":"9","author":"X Wang","year":"2022","unstructured":"Wang X, Shan M, Zhang S, Chen X, Liu W, Chen J, Liu X (2022) Stimuli-responsive antibacterial materials: molecular structures, design principles, and biomedical applications. Adv Sci 9:e2104843. https:\/\/doi.org\/10.1002\/advs.202104843","journal-title":"Adv Sci"},{"key":"10853_CR150","doi-asserted-by":"publisher","first-page":"9199","DOI":"10.1039\/d4tb01122h","volume":"12","author":"M Blanco Massani","year":"2024","unstructured":"Blanco Massani M, To D, Meile S, Schmelcher M, Gintsburg D, Cora\u00e7a-Huber DC, Seybold A, Loessner M, Bernkop-Schn\u00fcrch A (2024) Enzyme-responsive nanoparticles: enhancing the ability of endolysins to eradicate Staphylococcus aureus biofilm. J Mater Chem B 12:9199\u20139205. https:\/\/doi.org\/10.1039\/d4tb01122h","journal-title":"J Mater Chem B"},{"key":"10853_CR151","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jconrel.2019.06.013","volume":"307","author":"P Jelinkova","year":"2019","unstructured":"Jelinkova P, Mazumdar A, Sur VP, Kociova S, Dolezelikova K, Jimenez AMJ, Koudelkova Z, Mishra PK, Smerkova K, Heger Z, Vaculovicova M, Moulick A, Adam V (2019) Nanoparticle-drug conjugates treating bacterial infections. J Control Release 307:166\u2013185. https:\/\/doi.org\/10.1016\/j.jconrel.2019.06.013","journal-title":"J Control Release"},{"key":"10853_CR152","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1758","volume":"14","author":"N Osman","year":"2022","unstructured":"Osman N, Devnarain N, Omolo CA, Fasiku V, Jaglal Y, Govender T (2022) Surface modification of nano-drug delivery systems for enhancing antibiotic delivery and activity. WIREs Nanomed Nanobiotechnol 14:e1758. https:\/\/doi.org\/10.1002\/wnan.1758","journal-title":"WIREs Nanomed Nanobiotechnol"},{"key":"10853_CR153","doi-asserted-by":"publisher","first-page":"8001","DOI":"10.1021\/acsnano.1c00476","volume":"15","author":"Z Liqun","year":"2021","unstructured":"Liqun Z, Junmin Z, Jun S, Yizhen L, Xiangzhong R, Yanli Z (2021) Protein-based nanomedicine for therapeutic benefits of cancer. ACS Nano 15:8001\u20138038. https:\/\/doi.org\/10.1021\/acsnano.1c00476","journal-title":"ACS Nano"},{"key":"10853_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114525","volume":"190","author":"J Yang","year":"2022","unstructured":"Yang J, Wang X, Wang B, Park K, Wooley K, Zhang S (2022) Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers. Adv Drug Deliv Rev 190:114525. https:\/\/doi.org\/10.1016\/j.addr.2022.114525","journal-title":"Adv Drug Deliv Rev"},{"key":"10853_CR155","doi-asserted-by":"publisher","first-page":"7953","DOI":"10.1021\/acsnano.2c12448","volume":"17","author":"H Zhu","year":"2023","unstructured":"Zhu H, Zheng J, Oh XY, Chan CY, Low BQL, Tor JQ, Jiang W, Ye E, Loh XJ, Li Z (2023) Nanoarchitecture-integrated hydrogel systems toward therapeutic applications. ACS Nano 17:7953\u20137978. https:\/\/doi.org\/10.1021\/acsnano.2c12448","journal-title":"ACS Nano"},{"key":"10853_CR156","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1039\/d3tb02610h","volume":"12","author":"H Zhou","year":"2024","unstructured":"Zhou H, Zhu Y, Yang B, Huo Y, Yin Y, Jiang X, Ji W (2024) Stimuli-responsive peptide hydrogels for biomedical applications. J Mater Chem B 12:1748\u20131774. https:\/\/doi.org\/10.1039\/d3tb02610h","journal-title":"J Mater Chem B"},{"key":"10853_CR157","doi-asserted-by":"publisher","first-page":"12687","DOI":"10.1021\/acsnano.1c04206","volume":"15","author":"Y Liang","year":"2021","unstructured":"Liang Y, He J, Guo B (2021) Functional hydrogels as wound dressing to enhance wound healing. ACS Nano 15:12687\u201312722. https:\/\/doi.org\/10.1021\/acsnano.1c04206","journal-title":"ACS Nano"},{"key":"10853_CR158","doi-asserted-by":"publisher","unstructured":"Fangfang Y, Xinyu W, Yi-Lin L, Qi Y, Yuhong L (2021) Smart chimeric lysin ClyC loaded alginate hydrogel reduces Staphylococcus aureus induced bone infection. Front Mater 8\u20132021. https:\/\/doi.org\/10.3389\/fmats.2021.763297","DOI":"10.3389\/fmats.2021.763297"},{"key":"10853_CR159","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12929-024-01065-y","volume":"31","author":"DV Vasina","year":"2024","unstructured":"Vasina DV, Antonova NP, Gushchin VA, Aleshkin AV, Fursov MV, Fursova AD, Gancheva PG, Grigoriev IV, Grinkevich P, Kondratev AV, Kostarnoy AV, Lendel AM, Makarov VV, Nikiforova MA, Pochtovyi AA, Prudnikova T, Remizov TA, Shevlyagina NV, Siniavin AE, Smirnova NS, Terechov AA, Tkachuk AP, Usachev EV, Vorobev AM, Yakimakha VS, Yudin SM, Zackharova AA, Zhukhovitsky VG, Logunov DY, Gintsburg AL (2024) Development of novel antimicrobials with engineered endolysin LysECD7-SMAP to combat Gram-negative bacterial infections. J Biomed Sci 31:75. https:\/\/doi.org\/10.1186\/s12929-024-01065-y","journal-title":"J Biomed Sci"},{"key":"10853_CR160","doi-asserted-by":"publisher","DOI":"10.3390\/medicines6010007","volume":"6","author":"E Giuliano","year":"2018","unstructured":"Giuliano E, Paolino D, Fresta M, Cosco D (2018) Drug-loaded biocompatible nanocarriers embedded in poloxamer 407 hydrogels as therapeutic formulations. Medicines 6:7. https:\/\/doi.org\/10.3390\/medicines6010007","journal-title":"Medicines"},{"key":"10853_CR161","doi-asserted-by":"publisher","DOI":"10.3390\/v14091956","volume":"14","author":"C Li","year":"2022","unstructured":"Li C, Nyaruaba R, Zhao X, Xue H, Li Y, Yang H, Wei H (2022) Thermosensitive hydrogel wound dressing loaded with bacteriophage lysin LysP53. Viruses 14:1956. https:\/\/doi.org\/10.3390\/v14091956","journal-title":"Viruses"},{"key":"10853_CR162","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwae044","volume":"11","author":"Y Yang","year":"2024","unstructured":"Yang Y, Wang J, Huang S, Li M, Chen J, Pei D, Tang Z, Guo B (2024) Bacteria-responsive programmed self-activating antibacterial hydrogel to remodel regeneration microenvironment for infected wound healing. Natl Sci Rev 11:nwae044. https:\/\/doi.org\/10.1093\/nsr\/nwae044","journal-title":"Natl Sci Rev"},{"key":"10853_CR163","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202412154","volume":"36","author":"H Liu","year":"2024","unstructured":"Liu H, Wei X, Peng H, Yang Y, Hu Z, Rao Y, Wang Z, Dou J, Huang X, Hu Q, Tan L, Wang Y, Chen J, Liu L, Yang Y, Wu J, Hu X, Lu S, Shang W, Rao X (2024) LysSYL-loaded pH-switchable self-assembling peptide hydrogels promote methicillin-resistant Staphylococcus Aureus elimination and wound healing. Adv Mater 36:e2412154. https:\/\/doi.org\/10.1002\/adma.202412154","journal-title":"Adv Mater"},{"key":"10853_CR164","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202101820","volume":"11","author":"AM Gutierrez","year":"2022","unstructured":"Gutierrez AM, Frazar EM, Mv XK, Paul P, Hilt JZ (2022) Hydrogels and hydrogel nanocomposites: enhancing healthcare through human and environmental treatment. Adv Healthc Mater 11:e2101820. https:\/\/doi.org\/10.1002\/adhm.202101820","journal-title":"Adv Healthc Mater"},{"key":"10853_CR165","doi-asserted-by":"publisher","first-page":"890479","DOI":"10.3389\/fbioe.2022.890479","volume":"10","author":"KCP Cruz","year":"2022","unstructured":"Cruz KCP, Enekegho LO, Stuart DT (2022) Bioengineered probiotics: synthetic biology can provide live cell therapeutics for the treatment of foodborne diseases. Front Bioeng Biotechnol 10:890479. https:\/\/doi.org\/10.3389\/fbioe.2022.890479","journal-title":"Front Bioeng Biotechnol"},{"key":"10853_CR166","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nbt0298-181","volume":"16","author":"D Guido","year":"1998","unstructured":"Guido D, Andreas B, Ivaylo G, Zeljka S, Andreas S, Andr\u00e9 C, Stefan HEK, J\u00fcrgen H, Aladar AS, Werner G (1998) Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Nat Biotechnol 16:181\u2013185. https:\/\/doi.org\/10.1038\/nbt0298-181","journal-title":"Nat Biotechnol"},{"key":"10853_CR167","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1754-6834-7-104","volume":"7","author":"AK Piyum","year":"2014","unstructured":"Piyum AK, Dwayne RR, David MD, Stephen RH, Kenneth MB (2014) Saccharomyces cerevisiae expressing bacteriophage endolysins reduce Lactobacillus contamination during fermentation. Biotechnol Biofuels 7:104. https:\/\/doi.org\/10.1186\/1754-6834-7-104","journal-title":"Biotechnol Biofuels"},{"key":"10853_CR168","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1021\/acssynbio.9b00360","volume":"9","author":"J Chun","year":"2020","unstructured":"Chun J, Bai J, Ryu S (2020) Yeast surface display system for facilitated production and application of phage endolysin. ACS Synth Biol 9:508\u2013516. https:\/\/doi.org\/10.1021\/acssynbio.9b00360","journal-title":"ACS Synth Biol"},{"key":"10853_CR169","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijfoodmicro.2010.04.029","volume":"141","author":"P Garc\u00eda","year":"2010","unstructured":"Garc\u00eda P, Mart\u00ednez B, Rodr\u00edguez L, Rodr\u00edguez A (2010) Synergy between the phage endolysin LysH5 and nisin to kill Staphylococcus aureus in pasteurized milk. Int J Food Microbiol 141:151\u2013155. https:\/\/doi.org\/10.1016\/j.ijfoodmicro.2010.04.029","journal-title":"Int J Food Microbiol"},{"key":"10853_CR170","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1128\/mmbr.00017-08","volume":"72","author":"S Lebeer","year":"2008","unstructured":"Lebeer S, Vanderleyden J, De Keersmaecker SC (2008) Genes and molecules of lactobacilli supporting probiotic action. Microbiol Mol Biol Rev 72:728\u2013764. https:\/\/doi.org\/10.1128\/mmbr.00017-08","journal-title":"Microbiol Mol Biol Rev"},{"key":"10853_CR171","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.fm.2013.05.010","volume":"36","author":"S Messaoudi","year":"2013","unstructured":"Messaoudi S, Manai M, Kergourlay G, Pr\u00e9vost H, Connil N, Chobert JM, Dousset X (2013) Lactobacillus salivarius: bacteriocin and probiotic activity. Food Microbiol 36:296\u2013304. https:\/\/doi.org\/10.1016\/j.fm.2013.05.010","journal-title":"Food Microbiol"},{"key":"10853_CR172","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1039\/d1cs00617g","volume":"51","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Tang Z, Huang X, Chen W, Zhou J, Liu H, Liu C, Kong N, Tao W (2022) Emerging mRNA technologies: delivery strategies and biomedical applications. Chem Soc Rev 51:3828\u20133845. https:\/\/doi.org\/10.1039\/d1cs00617g","journal-title":"Chem Soc Rev"},{"key":"10853_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102145","volume":"35","author":"MK Jansson","year":"2024","unstructured":"Jansson MK, Nguyen DT, Mikkat S, Warnke C, Janssen MB, Warnke P, Kreikemeyer B, Patenge N (2024) Synthetic mRNA delivered to human cells leads to expression of Cpl-1 bacteriophage-endolysin with activity against Streptococcus pneumoniae. Mol Ther Nucleic Acids 35:102145. https:\/\/doi.org\/10.1016\/j.omtn.2024.102145","journal-title":"Mol Ther Nucleic Acids"},{"key":"10853_CR174","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/cid\/ciae043","volume":"78","author":"VG Fowler Jr.","year":"2024","unstructured":"Fowler VG Jr., Das AF, Lipka-Diamond J, Ambler JE, Schuch R, Pomerantz R, Cassino C, J\u00e1uregui-Peredo L, Moran GJ, Rupp ME, Lachiewicz AM, Kuti JL, Wise RA, Kaye KS, Zervos MJ, Nichols WG (2024) Exebacase in addition to standard-of-care antibiotics for Staphylococcus aureus bloodstream infections and right-sided infective endocarditis: a phase 3, superiority-design, placebo-controlled, randomized clinical trial (DISRUPT). Clin Infect Dis 78:1473\u20131481. https:\/\/doi.org\/10.1093\/cid\/ciae043","journal-title":"Clin Infect Dis"},{"key":"10853_CR175","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s41586-023-05696-3","volume":"614","author":"AH Yeh","year":"2023","unstructured":"Yeh AH, Norn C, Kipnis Y, Tischer D, Pellock SJ, Evans D, Ma P, Lee GR, Zhang JZ, Anishchenko I, Coventry B, Cao L, Dauparas J, Halabiya S, DeWitt M, Carter L, Houk KN, Baker D (2023) De novo design of luciferases using deep learning. Nature 614:774\u2013780. https:\/\/doi.org\/10.1038\/s41586-023-05696-3","journal-title":"Nature"},{"key":"10853_CR176","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.cell.2023.12.028","volume":"187","author":"T Kortemme","year":"2024","unstructured":"Kortemme T (2024) De novo protein design-from new structures to programmable functions. Cell 187:526\u2013544. https:\/\/doi.org\/10.1016\/j.cell.2023.12.028","journal-title":"Cell"},{"key":"10853_CR177","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.tim.2005.08.007","volume":"13","author":"VA Fischetti","year":"2005","unstructured":"Fischetti VA (2005) Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol 13:491\u2013496. https:\/\/doi.org\/10.1016\/j.tim.2005.08.007","journal-title":"Trends Microbiol"},{"key":"10853_CR178","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/b978-0-12-394438-2.00007-4","volume":"83","author":"DC Nelson","year":"2012","unstructured":"Nelson DC, Schmelcher M, Rodriguez-Rubio L, Klumpp J, Pritchard DG, Dong S, Donovan DM (2012) Endolysins as antimicrobials. Adv Virus Res 83:299\u2013365. https:\/\/doi.org\/10.1016\/b978-0-12-394438-2.00007-4","journal-title":"Adv Virus Res"},{"key":"10853_CR179","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrmicro2112","volume":"7","author":"K Ray","year":"2009","unstructured":"Ray K, Marteyn B, Sansonetti PJ, Tang CM (2009) Life on the inside: the intracellular lifestyle of cytosolic bacteria. Nat Rev Microbiol 7:333\u2013340. https:\/\/doi.org\/10.1038\/nrmicro2112","journal-title":"Nat Rev Microbiol"},{"key":"10853_CR180","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10930-013-9502-5","volume":"32","author":"GJ Gopal","year":"2013","unstructured":"Gopal GJ, Kumar A (2013) Strategies for the production of recombinant protein in Escherichia coli. Protein J 32:419\u2013425. https:\/\/doi.org\/10.1007\/s10930-013-9502-5","journal-title":"Protein J"},{"key":"10853_CR181","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1042\/EBC20240019","volume":"68","author":"E Cremelie","year":"2024","unstructured":"Cremelie E, Vazquez R, Briers Y (2024) A comparative guide to expression systems for phage lysin production. Essays Biochem 68:645\u2013659. https:\/\/doi.org\/10.1042\/EBC20240019","journal-title":"Essays Biochem"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10853-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-025-10853-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10853-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T19:03:58Z","timestamp":1784055838000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-025-10853-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":181,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10853"],"URL":"https:\/\/doi.org\/10.1007\/s12602-025-10853-3","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}